Vulnerability Description
The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certificate.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Pharmaguideline | Pharmaguideline | 1.2.0 |
Related Weaknesses (CWE)
References
- http://www.kb.cert.org/vuls/id/582497US Government Resource
- http://www.kb.cert.org/vuls/id/819305US Government Resource
- https://docs.google.com/spreadsheets/d/1t5GXwjw82SyunALVJb2w0zi3FoLRIkfGPc7AMjRF
- http://www.kb.cert.org/vuls/id/582497US Government Resource
- http://www.kb.cert.org/vuls/id/819305US Government Resource
- https://docs.google.com/spreadsheets/d/1t5GXwjw82SyunALVJb2w0zi3FoLRIkfGPc7AMjRF
FAQ
What is CVE-2014-6721?
CVE-2014-6721 is a vulnerability with a CVSS score of 5.4 (MEDIUM). The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain se...
How severe is CVE-2014-6721?
CVE-2014-6721 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2014-6721?
Check the references section above for vendor advisories and patch information. Affected products include: Pharmaguideline Pharmaguideline.